4d
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
SE has achieved rapid commercial success with VYVGART, driving $4.2 billion in 2025 sales and operational profitability. Learn more about ARGX stock here.
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will present data ...
Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...
Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat generalized myasthenia gravis (MG) in recent years: efgartigimod (Vyvgart), ...
MG Motor India finally revealed the new MG Majestor SUV in the Indian market. The SUV was first showcased at the 2025 Bharat Mobility Expo and is essentially a heavily updated version of the Gloster.
The MarketWatch News Department was not involved in the creation of this content. LEXINGTON, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- KabaFusion (the "Company"), a nationally recognized leader in home ...
LEXINGTON, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- KabaFusion (the “Company”), a nationally recognized leader in home and alternative site infusion, and Nautic Partners (“Nautic”) announced today ...
If you’re anything like me, you’ve likely learned to approach new beauty launches with a healthy dose of skepticism—especially those that promise overnight results or claim to replicate pricey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results